insights_auto
Outlook: 50.0% bullish·0.0% bearish
Go to analysischevron_right
SHL:ASX
Sonic Healthcare Ltd
A$18.79
arrow_downward
-0.63%(-0.12) 1D
Sep 25, 4:10:10 PM GMT+10 · AUD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHL...
Open
A$18.80
High
A$18.98
Low
A$18.68
Mkt. cap
9.29B
Avg. vol.
4.44M
Volume
1.95M
Dividend
5.75%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 2, 2026
P/E ratio
15.28
52-wk high
A$24.27
52-wk low
A$18.26
EPS
A$1.23
Shares outstanding
494.24M
No. of employees
45K
Open
A$18.80
High
A$18.98
Low
A$18.68
Mkt. cap
9.29B
Avg. vol.
4.44M
Volume
1.95M
Dividend
5.75%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 2, 2026
P/E ratio
15.28
52-wk high
A$24.27
52-wk low
A$18.26
EPS
A$1.23
Shares outstanding
494.24M
No. of employees
45K
News stories
From web sources and news partners
TipRanks
·
1 day ago
Sonic Healthcare Updates Share Registry Address for Investors
TipRanks
·
1 day ago
Sonic Healthcare Tightens Oversight of Unaudited and Climate Disclosures in 2026 Report
TipRanks
·
1 day ago
Sonic Healthcare Files Updated ASX Corporate Governance Disclosures
Profile
Sonic Healthcare Limited is a Sydney-based, Australian company that provides laboratory services, pathology, radiology services and primary care medical services. Wikipedia
About Sonic Healthcare Ltd
CEOColin S. Goldschmidt M.D.
Employees45K
Founded1934
HeadquartersSydney, New South Wales, Australia
SectorHealth care provider
Websitesonichealthcare.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in AUD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.72B | 2.72B | 2.71B | 2.71B |
Cost of goods sold | 1.84B | 1.84B | 1.80B | 1.80B |
Cost of revenue | 1.84B | 1.84B | 1.80B | 1.80B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 84.51M | 84.51M | 79.15M | 79.15M |
Operating expense | 636.48M | 636.48M | 653.98M | 653.98M |
Total operating expenses | 2.48B | 2.48B | 2.45B | 2.45B |
Operating income | 244.41M | 244.41M | 257.56M | 257.56M |
Other non operating income | - | - | - | - |
EBT including unusual items | 188.44M | 188.44M | 223.83M | 223.83M |
EBT excluding unusual items | 192.32M | 192.32M | 207.99M | 207.99M |
Income tax expense | 49.90M | 49.90M | 44.21M | 44.21M |
Effective tax rate | 26.48% | 26.48% | 19.75% | 19.75% |
Other operating expenses | 334.84M | 334.84M | 357.44M | 357.44M |
Net income | 131.24M | 131.24M | 172.90M | 172.90M |
Net profit margin | 4.82% | 4.82% | 6.38% | 6.38% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | - | - |
Interest expense | -52.09M | -52.09M | -49.56M | -49.56M |
Net interest expenses | -52.09M | -52.09M | -49.56M | -49.56M |
Depreciation and amortization charges | 192.74M | 192.74M | 193.01M | 193.01M |
EBITDA | 461.55M | 461.55M | 474.94M | 474.94M |
Gain or loss from assets sale | - | - | - | - |